230 related articles for article (PubMed ID: 34794045)
1. Influence of inter-electrode distance on subthalamic nucleus local field potential recordings in Parkinson's disease.
Averna A; Marceglia S; Arlotti M; Locatelli M; Rampini P; Priori A; Bocci T
Clin Neurophysiol; 2022 Jan; 133():29-38. PubMed ID: 34794045
[TBL] [Abstract][Full Text] [Related]
2. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
[TBL] [Abstract][Full Text] [Related]
3. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
[TBL] [Abstract][Full Text] [Related]
4. High frequency oscillations in the subthalamic nucleus: a neurophysiological marker of the motor state in Parkinson's disease.
Özkurt TE; Butz M; Homburger M; Elben S; Vesper J; Wojtecki L; Schnitzler A
Exp Neurol; 2011 Jun; 229(2):324-31. PubMed ID: 21376039
[TBL] [Abstract][Full Text] [Related]
5. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease.
Giannicola G; Rosa M; Marceglia S; Scelzo E; Rossi L; Servello D; Menghetti C; Pacchetti C; Zangaglia R; Locatelli M; Caputo E; Cogiamanian F; Ardolino G; Barbieri S; Priori A
Neurosignals; 2013; 21(1-2):89-98. PubMed ID: 22538235
[TBL] [Abstract][Full Text] [Related]
6. Effects of Contralateral Deep Brain Stimulation and Levodopa on Subthalamic Nucleus Oscillatory Activity and Phase-Amplitude Coupling.
Farokhniaee A; Marceglia S; Priori A; Lowery MM
Neuromodulation; 2023 Feb; 26(2):310-319. PubMed ID: 36513587
[TBL] [Abstract][Full Text] [Related]
7. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
[TBL] [Abstract][Full Text] [Related]
8. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.
Priori A; Foffani G; Pesenti A; Tamma F; Bianchi AM; Pellegrini M; Locatelli M; Moxon KA; Villani RM
Exp Neurol; 2004 Oct; 189(2):369-79. PubMed ID: 15380487
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease.
Androulidakis AG; Kühn AA; Chen CC; Blomstedt P; Kempf F; Kupsch A; Schneider GH; Doyle L; Dowsey-Limousin P; Hariz MI; Brown P
Brain; 2007 Feb; 130(Pt 2):457-68. PubMed ID: 17213215
[TBL] [Abstract][Full Text] [Related]
10. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
[TBL] [Abstract][Full Text] [Related]
11. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
[TBL] [Abstract][Full Text] [Related]
12. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
[TBL] [Abstract][Full Text] [Related]
13. Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.
Kühn AA; Kupsch A; Schneider GH; Brown P
Eur J Neurosci; 2006 Apr; 23(7):1956-60. PubMed ID: 16623853
[TBL] [Abstract][Full Text] [Related]
14. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
Wang DD; de Hemptinne C; Miocinovic S; Qasim SE; Miller AM; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
Neurobiol Dis; 2016 May; 89():213-22. PubMed ID: 26884091
[TBL] [Abstract][Full Text] [Related]
15. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
[TBL] [Abstract][Full Text] [Related]
16. Eight cylindrical contact lead recordings in the subthalamic region localize beta oscillations source to the dorsal STN.
Tamir I; Wang D; Chen W; Ostrem JL; Starr PA; de Hemptinne C
Neurobiol Dis; 2020 Dec; 146():105090. PubMed ID: 32977021
[TBL] [Abstract][Full Text] [Related]
17. Complementary roles of different oscillatory activities in the subthalamic nucleus in coding motor effort in Parkinsonism.
Tan H; Pogosyan A; Anzak A; Ashkan K; Bogdanovic M; Green AL; Aziz T; Foltynie T; Limousin P; Zrinzo L; Brown P
Exp Neurol; 2013 Oct; 248():187-95. PubMed ID: 23778147
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
19. Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.
Huebl J; Spitzer B; Brücke C; Schönecker T; Kupsch A; Alesch F; Schneider GH; Kühn AA
Cortex; 2014 Nov; 60():69-81. PubMed ID: 24713195
[TBL] [Abstract][Full Text] [Related]
20. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
